Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

PURPOSE: The aim of this study was to compare disease-free survival (DFS) and overall survival (OS) between clinically node-positive breast cancer patients, treated with neoadjuvant chemotherapy (NAC), with axillary pathologic complete response (ypN0), residual axillary isolated tumor cells or micro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Breast Cancer Res Treat
Asıl Yazarlar: van Nijnatten, T. J. A., Simons, J. M., Moossdorff, M., de Munck, L., Lobbes, M. B. I., van der Pol, C. C., Koppert, L. B., Luiten, E. J. T., Smidt, M. L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2017
Konular:
Epidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387009/
https://ncbi.nlm.nih.gov/pubmed/28213782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4157-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller